Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 4.14 EX-4.14 Fourth Supplemental Indenture to Indenture Dated As of August 11, 2009
- 4.15 EX-4.15 Fifth Supplemental Indenture to Indenture Dated As of August 11, 2009
- 4.16 EX-4.16 Sixth Supplemental Indenture to Indenture Dated As of August 11, 2009
- 4.17 EX-4.17 Seventh Supplemental Indenture to Indenture Dated As of August 11, 2009
- 5.1 EX-5.1 Form of Opinion of Foley Hoag LLP
- 5.2 EX-5.2 Form of Opinion of Perkins Coie LLP
- 5.3 EX-5.3 Form of Opinion of Perkins Coie LLP
- 5.4 EX-5.4 Form of Opinion of Greenberg Traurig P.a.
- 5.5 EX-5.5 Form of Opinion of Greenberg Traurig LLP
- 5.6 EX-5.6 Form of Opinion of Troutman Sanders LLP
- 5.7 EX-5.7 Form of Opinion of Venable LLP
- 12.1 EX-12.1 Statement Regarding Computation of Ratio of Earnings to Fixed Charges
- 12.2 EX-12.2 Statement Regarding Computation of Ratio of Earnings to Combined Fixed Charges and Preference Dividends
- 23.1 EX-23.1 Consent of Bdo Seidman, LLP
- 23.2 EX-23.2 Consent of KPMG LLP
- 23.3 EX-23.3 Consent of Ernst & Young LLP
- 23.4 EX-23.4 Consent of Grant Thornton Zhongua
- 23.5 EX-23.5 Consent of Stonefield Josephson, Inc.
- 25.1 EX-25.1 Statement of Eligibility
- 99.1 EX-99.1 Form of Letter of Transmittal
- 99.2 EX-99.2 Form of Notice Guaranteed Delivery
- 99.3 EX-99.3 Form of Letter to Registered Holders and DTC Participants
- 99.4 EX-99.4 Form of Letter to Clients
Alere San Diego similar filings
- 26 Nov 10 Registration of securities issued in business combination transactions
- 19 Apr 10 Registration of securities issued in business combination transactions (amended)
- 26 Mar 10 Registration of securities issued in business combination transactions (amended)
- 12 Feb 10 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” in the Registration Statement(Form S-4) and related Prospectus of Inverness Medical Innovations, Inc. for the offering to exchange up to $100,000,000 aggregate principal amount of our new 7.875% Senior Notes due 2016, which have been registered under the Securities Act of 1933 for any and all of our outstanding unregistered 7.875% Senior Notes due 2016 that we issued on September 28, 2009 and to the incorporation by reference therein of our report dated February 23, 2007, with respect to the consolidated financial statements of Biosite Incorporated, originally included in its Annual Report(Form 10-K) for the year ended December 31, 2006, and incorporated by reference in the Current Report onForm 8-K of Inverness Medical Innovations, Inc., dated June 26, 2007, filed with the Securities and Exchange Commission on July 2, 2007, and as amended on July 20, 2007.
/s/ Ernst & Young LLP
San Diego, California
February 12, 2010